MFDS — authorised 27 February 2008
- Marketing authorisation holder: REGENERON PHARMACEUTICALS
- Status: likely_approved
🇰🇷 Arcalyst in South Korea
MFDS authorised Arcalyst on 27 February 2008
Marketing authorisation
Arcalyst in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in South Korea
Frequently asked questions
Is Arcalyst approved in South Korea?
Yes. MFDS authorised it on 27 February 2008.
Who is the marketing authorisation holder for Arcalyst in South Korea?
REGENERON PHARMACEUTICALS holds the South Korean marketing authorisation.